A new preclinical study has found that a combination of viral and bacterial insults may be a key disease mechanism…
Articles by Lindsey Shapiro, PhD
Access to hepatitis C treatment and care remains low among children and recently pregnant women in the U.S., according…
Umecrine Cognition has raised around $2.5 million to support an ongoing Phase 1b/2a clinical trial testing its investigational therapy…
Pemvidutide resolved metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty liver disease, without worsening liver scarring (fibrosis) for…
Daily treatment with the diabetes medication dapagliflozin eased disease severity for people with metabolic dysfunction-associated steatohepatitis (MASH), a severe form…
The global prevalence of primary sclerosing cholangitis (PSC), or the total number of existing cases, is expected to increase…
The investigational treatment imdusiran used as part of combination therapy regimens has led to a functional cure for eight…
AHB-137, Ausperbio’s experimental therapy, safely and effectively suppressed the disease-causing hepatitis B virus (HBV) in people with chronic…
Daily treatment with Ipsen’s elafibranor safely and effectively eases itching, stabilizes liver scarring, and reduces liver damage biomarkers in…
Rare mutations in the MET gene can cause metabolic dysfunction-associated steatotic liver disease (MASLD), a form of fatty liver…